ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 146 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,955 | -19.7% | 32,985 | +0.1% | 0.00% | – |
| Q2 2023 | $123,192 | +20.9% | 32,939 | +8.3% | 0.00% | – |
| Q1 2023 | $101,863 | -90.4% | 30,407 | -86.2% | 0.00% | -100.0% |
| Q4 2022 | $1,058,715 | -15.3% | 220,107 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,250,645 | -20.0% | 219,797 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,564,187 | -16.0% | 220,308 | -14.8% | 0.00% | 0.0% |
| Q1 2022 | $1,861,676 | -7.4% | 258,655 | +15.6% | 0.00% | 0.0% |
| Q4 2021 | $2,010,000 | -79.8% | 223,655 | -21.1% | 0.00% | -87.5% |
| Q3 2021 | $9,937,000 | +61.3% | 283,423 | -1.2% | 0.01% | +60.0% |
| Q2 2021 | $6,161,000 | -61.5% | 286,840 | +10.5% | 0.01% | -64.3% |
| Q1 2021 | $16,023,000 | +48.5% | 259,476 | +0.5% | 0.01% | +40.0% |
| Q4 2020 | $10,791,000 | – | 258,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |